
|Articles|July 1, 2006
Botulinum toxin A shows efficacy in treating BPH
Atlanta-Intraprostatic injection of botulinum toxin A (Botox) is a safe and effective treatment in patients with symptomatic BPH that results in improvements in symptoms and quality of life that may persist for up to 1 year, Chinese researchers reported at the AUA annual meeting here.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
High PHI scores are linked to increased odds of significant prostate cancer
2
Trial to evaluate novel combination in BCG-unresponsive NMIBC
3
Dosing begins in trial of alpha radioligand therapy for mCRPC
4
FDA grants fast track designation to Enolen for localized prostate cancer
5




















